Epstein-barr virus-associated nasopharyngeal carcinoma and local polymorphic B-cell lymphoproliferative disorder in a patient with HIV disease

Journal of the International Association of Physicians in AIDS Care

Volumn 6, Issue 4, 2007, Pages 255-259

  Manfredi, Roberto ^a   Sabbatani, Sergio ^a   Gianelli, Umberto ^b   Marinacci, Ginevra ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

diagnosis; Epstein Bar virus; HIV; lymphoproliferative disorder; management; nasopharyngeal carcinoma; pathogenesis

Indexed keywords

B LYMPHOCYTE; CASE REPORT; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HIV INFECTIONS; HUMAN; LYMPHOPROLIFERATIVE DISEASE;

B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 54849410683     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109707302070     Document Type: Article

References (24)

1. Flaitz CM, Hicks MJ Molecular piracy: the viral link to carcinogenesis. Oral Oncol. 1998 ; 34: 448-453. (Pubitemid 28546857)
2. Andersson J. An overview of Epstein-Barr virus: from discovery to future directions for treatment and prevention. Herpes. 2000 ; 7: 76-82.
3. Herrmann K., Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol. 2003 ; 199: 140-145. (Pubitemid 36176018)
4. Sacaze C., Henry S., Icart J., Mariame B. Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients. Virus Res. 2001 ; 81: 133-142. (Pubitemid 33001371)
5. Gurtney TA, Murr AH Otolaryngologic manifestations of human immunodeficiency virus infection. Otolaryngol Clin North Am. 2003 ; 36: 607-624. (Pubitemid 36897475)
6. Rivera S., Keryer C., Busson P., Maingon P. Nasopharingeal carcinomas: from biology to clinic. Cancer Radiother. 2005 ; 9: 55-68.
7. Wei WI, Sham JS Nasopharyngeal carcinoma. Lancet. 2005 ; 365: 2041-2054. (Pubitemid 40812341)
8. Wong MM, Lye MS, Cheng HM, Sam CK Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma. Asian Pac J Allergy Immunol. 2005 ; 23: 65-67. (Pubitemid 40790090)
9. Kingma DW, Weiss WB, Jaffe ES, Kumar S., Frekko K., Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood. 1996 ; 88: 242-251. (Pubitemid 26230693)
10. Loughrey M., Trivett M., Lade S., Murray W., Turner H., Waring P. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridization. Pathology. 2004 ; 36: 301-308. (Pubitemid 39178968)
11. Burgos JS Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol. 2005 ; 22: 113-122.
12. Canioni D., Arnulf B., Asso-Bonnet M., Raphael M., Brousse N. Nasal natural killer lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus. Arch Pathol Lab Med. 2001 ; 125: 660-662. (Pubitemid 32429815)
13. Shahab I., Osborne BM, Butler J.J. Nasopharyngeal lymphoid tissue masses in patients with human immunodeficiency virus-1: histologic findings and clinical correlations. Cancer. 1994 ; 74: 3083-3088. (Pubitemid 24375062)
14. Kieserman SP, Stern J. Malignant transformation of nasopharyngeal lymphoid hyperplasia. Otolaryngol Head Neck Surg. 1995 ; 113: 474-476.
15. Wang MC, Tsai TL, Liu CY, Shu CH, Lin CZ Nasopharyngeal lymphoid hyperplasia of an HIV carrier, mimicking nasopharyngeal cancer. J Chin Med Assoc. 2003 ; 66: 189-191.
16. Robinson MR, Salit RB, Bryant-Greenwood PK, et al. Burkitt's/Burkitt's- like lymphoma presenting as bacterial sinusitis in two HIV-infected children. AIDS Patient Care STDs. 2001 ; 15: 453-458. (Pubitemid 32937605)
17. Van der Vliet HJ, Van Oers MH, Schot LJ, Majoie CB, Van der Meer JT A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient. Ann Hematol. 2002 ; 81: 164-166. (Pubitemid 36067598)
18. Cesarman E., Mesri EA Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Curr Top Microbiol Immunol. 2007 ; 312: 263-287. (Pubitemid 47400340)
19. Hald J., Larsen PL Nasopharyngeal carcinoma in an HIVpositive patient causing severe morbidity and early death. J Laryngol Otol. 1993 ; 107: 149-150. (Pubitemid 23209061)
20. Chintu C., Athale UH, Patil PS Childhood cancers in Zambia before and after the HIV epidemic. Arch Dis Child. 1995 ; 73: 100-105.
21. Singh B., Bhaya M., Zimbler M., et al. Impact of comorbidity on outcome of young patients with head and neck squamous cells carcinoma. Head Neck. 1998 ; 20: 1-7.
22. Wang N., Wu QL, Fang Y., et al. Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. J Transl Med. 2005 ; 3: 26.
23. Gottschalk S., Heslop HE, Roon CM Treatment of Epstein-Barr virus-associated malignancies with specific T cells. Adv Cancer Res. 2002 ; 84: 175-201. (Pubitemid 34188197)
24. Zhu K., Levine RS, Brann EA, Gnepp DR, Baum MK Cigarette smoking and nasopharyngeal cancer: an analysis of the relationship according to age at starting smoking and age at diagnosis. J Epidemiol. 1997 ; 7: 107-111. (Pubitemid 127824092)